GAP-Protected Solution-Phase Peptide Synthesis Without Polymer Supports
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current peptide synthesis methods face challenges such as high costs, difficulty in scale-up, and the need for expensive polymer supports, particularly in solid-phase peptide synthesis (SPPS), which limits the efficiency and economic viability of peptide production.
Innovation Solution
The development of a solution-phase peptide synthesis system using a Group-Assisted Purification (GAP) benzyl-type protecting group for C-terminus protection, allowing for peptide synthesis without chromatography, recrystallization, or polymer supports, and enabling high yield and purity peptide production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If solid-phase peptide synthesis (SPPS) with polymer supports is used, then purification is facilitated and column chromatography is avoided, but the cost increases and scale-up becomes difficult
Solution Approach 1:
The patent replaces expensive, reusable polymer supports with disposable, soluble protecting groups (Pgs) that are incorporated into the peptide sequence. These Pgs are cheap, easily removed by simple filtration after precipitation, and do not require regeneration or cleaning, enabling cost-effective scale-up while maintaining purification benefits
Solution Approach 2:
The patent changes the physical state of the protecting group from solid polymer support to soluble molecular compound. By using soluble Pgs that can be removed through precipitation and filtration rather than requiring column chromatography, the method achieves both easy purification and scalable production
2Ease of operation
If traditional protecting groups are used in solution-phase synthesis, then the synthesis can proceed, but purification requires column chromatography or recrystallization
Solution Approach 1:
The patent extracts the purification function from complex column chromatography or recrystallization processes by incorporating a specialized protecting group (Pg) that enables simple filtration-based purification. The Pg-modified peptide precipitates selectively from solution, allowing impurities to be removed by filtration alone
Solution Approach 2:
The protecting group acts as an intermediary that mediates between the synthesis process and purification step. By incorporating the Pg into the peptide sequence during synthesis, it enables subsequent easy purification through precipitation and filtration, bridging the gap between solution-phase synthesis and simplified purification
3Ease of manufacture
If polymer supports are used in SPPS, then purification is simplified, but the majority of material mass is occupied by the support rather than product
Solution Approach 1:
The patent replaces bulky, inert polymer supports with minimal, functional protecting groups that are incorporated into the peptide sequence. These Pgs add negligible mass compared to the peptide product, maximizing product concentration while maintaining purification simplicity through precipitation and filtration
Solution Approach 2:
The patent applies the protecting group function locally at specific positions in the peptide sequence rather than using bulk polymer supports. This localized approach maintains the purification benefits while minimizing the amount of non-product material present in the system
Data Source
AI summary
Disclosed is a system and method for Fmoc/tBu solution-phase peptide synthesis including the development of a new benzyl-type GAP protecting group, and related uses thereto. This novel GAP protecting group is utilized in place of a polymer support, facilitating C to N Fmoc peptide synthesis without chromatography, recrystallization, or polymer supports. The GAP group can be added and removed in high yield.